Vanta Bioscience Ltd Intrinsic Value
VANTABIO · Healthcare · Current price ₹19.64
Is Vanta Bioscience Ltd undervalued?
DocStoX estimates the fair value of Vanta Bioscience Ltd at ₹25 per share, versus the current market price of ₹20. That puts the stock about +27.3% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹25). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹21 (bear) to ₹25 (base) to ₹29 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹20 versus an intrinsic value of ₹25, Vanta Bioscience Ltd currently offers +27.3% of margin.
More on Vanta Bioscience Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.